298 related articles for article (PubMed ID: 18986819)
21. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
[TBL] [Abstract][Full Text] [Related]
22. Crimean-Congo hemorrhagic fever in Iran and neighboring countries.
Chinikar S; Ghiasi SM; Hewson R; Moradi M; Haeri A
J Clin Virol; 2010 Feb; 47(2):110-4. PubMed ID: 20006541
[TBL] [Abstract][Full Text] [Related]
23. The frequency of self-reported allergic diseases in patients with crimean-congo haemorrhagic fever.
Abadoglu O; Engin A
Allergol Immunopathol (Madr); 2009; 37(5):234-8. PubMed ID: 19775796
[TBL] [Abstract][Full Text] [Related]
24. Knowledge levels about Crimean-Congo hemorrhagic fever among midwifery and nursing students in Kahramanmaras, Turkey.
Ozer A; Miraloglu M; Ekerbicer HC; Cevik F; Aloglu N
Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):77-84. PubMed ID: 20578485
[TBL] [Abstract][Full Text] [Related]
25. Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever.
Akinci E; Yilmaz M; Bodur H; Ongürü P; Bayazit FN; Erbay A; Ozet G
Int J Infect Dis; 2009 Sep; 13(5):560-3. PubMed ID: 19112036
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of epidemiological, clinical, and laboratory characteristics and mortality rate of patients with Crimean-Congo hemorrhagic fever in the northeast region of Turkey.
Karakecili F; Cikman A; Aydin M; Binay UD; Kesik OA; Ozcicek F
J Vector Borne Dis; 2018; 55(3):215-221. PubMed ID: 30618448
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of the M RNA segment of Crimean-Congo hemorrhagic fever virus strains in Turkey.
Ozdarendeli A; Aydin K; Tonbak S; Aktas M; Altay K; Koksal I; Bolat Y; Dumanli N; Kalkan A
Arch Virol; 2008; 153(1):37-44. PubMed ID: 17955162
[TBL] [Abstract][Full Text] [Related]
29. A newly identified Crimean-Congo hemorrhagic fever virus strain in Turkey.
Elevli M; Ozkul AA; Civilibal M; Midilli K; Gargili A; Duru NS
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e213-6. PubMed ID: 20005760
[TBL] [Abstract][Full Text] [Related]
30. Crimean-Congo hemorrhagic fever in southeastern Europe.
Vorou RM
Int J Infect Dis; 2009 Nov; 13(6):659-62. PubMed ID: 19540787
[TBL] [Abstract][Full Text] [Related]
31. Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome.
Tasdelen Fisgin N; Fisgin T; Tanyel E; Doganci L; Tulek N; Guler N; Duru F
Am J Hematol; 2008 Jan; 83(1):73-6. PubMed ID: 17597475
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in molecular biology of Crimean-Congo hemorrhagic fever.
Morikawa S; Saijo M; Kurane I
Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):375-89. PubMed ID: 17692916
[TBL] [Abstract][Full Text] [Related]
33. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever.
Bodur H; Akinci E; Ongürü P; Uyar Y; Baştürk B; Gözel MG; Kayaaslan BU
Int J Infect Dis; 2010 Aug; 14(8):e704-7. PubMed ID: 20627646
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey.
Duran A; Küçükbayrak A; Ocak T; Hakyemez NI; Taþ T; Karadađ M; Mengelođlu ZF
Afr Health Sci; 2013 Jun; 13(2):233-42. PubMed ID: 24235918
[TBL] [Abstract][Full Text] [Related]
35. Clinical investigation of the transient evoked otoacoustic emission test in Crimean-Congo hemorrhagic fever.
Engin A; Yildirim A; Kunt T; Bakir M; Dokmetas I; Ozdemir L
Int J Infect Dis; 2008 Mar; 12(2):162-5. PubMed ID: 17714968
[TBL] [Abstract][Full Text] [Related]
36. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.
Keshtkar-Jahromi M; Kuhn JH; Christova I; Bradfute SB; Jahrling PB; Bavari S
Antiviral Res; 2011 May; 90(2):85-92. PubMed ID: 21362441
[TBL] [Abstract][Full Text] [Related]
37. Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus.
Mild M; Simon M; Albert J; Mirazimi A
J Gen Virol; 2010 Jan; 91(Pt 1):199-207. PubMed ID: 19812264
[TBL] [Abstract][Full Text] [Related]
38. The risk of transmission of Crimean-Congo hemorrhagic fever virus from human cases to first-degree relatives.
Izadi S; Salehi M; Holakouie-Naieni K; Chinikar S
Jpn J Infect Dis; 2008 Nov; 61(6):494-6. PubMed ID: 19050365
[TBL] [Abstract][Full Text] [Related]
39. Medical examiners and Crimean-Congo hemorrhagic fever contamination risk.
Ozsoy S; Gokmen A; Ozdemir M; Akduman B; Korkusuz I; Javan GT
J Forensic Leg Med; 2015 Nov; 36():32-6. PubMed ID: 26367781
[TBL] [Abstract][Full Text] [Related]
40. Crimean-Congo hemorrhagic fever in Albania, 2001.
Papa A; Bino S; Llagami A; Brahimaj B; Papadimitriou E; Pavlidou V; Velo E; Cahani G; Hajdini M; Pilaca A; Harxhi A; Antoniadis A
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):603-6. PubMed ID: 12226691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
